{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:85519"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:85519","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Characterisation of therapeutic approaches for Alzheimer's dementia in the APP mouse model - neurotrophic factors and sensory stimulation","abstract":"Abstract not currently available.","abstract_html":"Abstract not currently available.","abstract_has_math":false,"creators":["Lo, Kai"],"institution":"University of Glasgow","degree_name":null,"degree_level":"PhD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-19T08:37:21Z","subjects":["RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.5525/gla.thesis.85519","outbound_label":"DOI","outbound_source":"dc:identifier.doi","record_url":"https://doi.org/10.5525/gla.thesis.85519","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier.doi","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A85519","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Lo, Kai"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:date.issued","label":"Date","values":["2025"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/85519/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights.embargoreason","label":"Dc Rights Embargoreason","values":["Chapter 4 involves the use of the drug ENT-A061 which is patented by the laboratory of Prof. Ioannis Charalampopoulos at the University of Crete, Greece. We have discussed public access to this thesis with Prof. Charalampopoulos and decided to ask that access is restricted for a period of three years for the following reasons: 1. Parts of the thesis are due for publication; 2. The thesis contains commercially sensitive information, the release of which might prejudice the commercial interests of our collaborators, in Prof. Charalampopoulos research group; 3. The thesis includes material that was obtained under a promise of confidentiality to Prof. Charalampopoulos until their results are published. Request to restrict beyond 3 years: Depending on publication progress with our collaborators in Prof. Charalampopoulos group, over the coming three years, it may be necessary to restrict public access to the thesis beyond the first three years. We will contact the theses team in 30 months time from now to confirm."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.5525/gla.thesis.85519"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Abstract not currently available."]},{"key":"dc:title","label":"Title","values":["Characterisation of therapeutic approaches for Alzheimer's dementia in the APP mouse model - neurotrophic factors and sensory stimulation"]}]}],"canonical_facts":{"dc:creator":["Lo, Kai"],"dc:date":["2025"],"dc:date.issued":["2025"],"dc:description.abstract":["Abstract not currently available."],"dc:identifier.doi":["10.5525/gla.thesis.85519"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/85519/"],"dc:rights.embargoreason":["Chapter 4 involves the use of the drug ENT-A061 which is patented by the laboratory of Prof. Ioannis Charalampopoulos at the University of Crete, Greece. We have discussed public access to this thesis with Prof. Charalampopoulos and decided to ask that access is restricted for a period of three years for the following reasons: 1. Parts of the thesis are due for publication; 2. The thesis contains commercially sensitive information, the release of which might prejudice the commercial interests of our collaborators, in Prof. Charalampopoulos research group; 3. The thesis includes material that was obtained under a promise of confidentiality to Prof. Charalampopoulos until their results are published. Request to restrict beyond 3 years: Depending on publication progress with our collaborators in Prof. Charalampopoulos group, over the coming three years, it may be necessary to restrict public access to the thesis beyond the first three years. We will contact the theses team in 30 months time from now to confirm."],"dc:subject":["RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry"],"dc:title":["Characterisation of therapeutic approaches for Alzheimer's dementia in the APP mouse model - neurotrophic factors and sensory stimulation"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["PhD"]},"updated_at":"2026-11-19T08:37:21Z"}